ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 302

$578K Total Retail Price of All Prescriptions

Rank: 12 out of 302

348 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

4% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,415 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 471 417 1 2
SIMVASTATIN 407 318 2 3
LEVOTHYROXINE SODIUM 371 298 3 9
LISINOPRIL 360 300 4 1
FUROSEMIDE 358 320 5 4
TRAMADOL HCL 276 200 6 16
MIRTAZAPINE 217 217 7 38
METOPROLOL TARTRATE 198 170 8 5
OMEPRAZOLE 196 135 9 7
ATENOLOL 172 143 10 20
LOSARTAN POTASSIUM 168 140 11 24
CITALOPRAM HBR 163 137 12 30
POTASSIUM CHLORIDE 160 125 13 55
PRAVASTATIN SODIUM 153 136 14 17
METFORMIN HCL 144 99 15 13
ALLOPURINOL 141 106 16 77
GABAPENTIN 136 68 17 18
HYDROCHLOROTHIAZIDE 133 110 18 12
LOVASTATIN 133 110 18 63
LANTUS 129 118 20 66
DONEPEZIL HCL 127 127 21 27
RISPERIDONE 123 106 22 40
TRIAMTERENE-HCTZ 123 109 22 122
SERTRALINE HCL 119 105 24 43
PANTOPRAZOLE SODIUM 118 117 25 25
RANITIDINE HCL 113 113 26 33
ATORVASTATIN CALCIUM 110 93 27 10
METOPROLOL SUCCINATE 109 101 28 6
JANTOVEN 105 103 29 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 104 30 53
CLOPIDOGREL 99 86 31 23
WARFARIN SODIUM 98 94 32 8
GLYBURIDE 87 49 R 33 111
PLAVIX 86 75 34 46
DIOVAN 82 76 35 60
METFORMIN HCL ER 80 62 36 125
VENTOLIN HFA 78 67 37 127
KLOR-CON M20 77 58 38 107
DIGOXIN 76 75 39 57
CIPROFLOXACIN HCL 75 67 40 58
CEFUROXIME 73 58 41 193
POLYETHYLENE GLYCOL 3350 70 68 42 102
NEXIUM 70 50 42 47
CARVEDILOL 69 56 44 19
TAMSULOSIN HCL 69 66 44 41
HYDRALAZINE HCL 66 57 46 48
NAMENDA 64 62 47 67
SPIRONOLACTONE 62 49 48 108
VOLTAREN 61 59 49 257
OXYCODONE-ACETAMINOPHEN 58 30 S2 50 22
AZITHROMYCIN 55 44 51 79
FENOFIBRATE 52 45 52 283
FELODIPINE ER 51 48 53 207
PROAIR HFA 50 0 54 81
PREDNISONE 50 44 54 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.